The Cancer Research Institute (CRI) is an amazing nonprofit offering a plethora of Immunotherapy resources to gain knowledge, stay updated, seek Clinical Trial offerings and to connect with fellow cancer patients/caregivers/medical personnel. CRI funds promising Immunotherapy research that is changing the cancer treatment landscape and is saving and changing lives. Knowledge is power and as a Patient Advocate, I have been fortunate to participate as a Patient Speaker and attend several of their annual Immunotherapy Patient Summits. I am always in awe of the Researchers and Doctors asked to share their work at the Patient Summits. Knowledge, Hope, Inspiration and Support is transpired to all those that attend the annual Patient Summits. I applaud CRI for all that they do and for funding Immunotherapy Research so that I could still be here alive today!
Cancer Research Institute is the oldest non profit organization focusing on immunotherapy and funds the best scientists in the field . By sharing my story and experience with immunotherapy CRI has given me a chance to give back and share hope with other patients. Their Immunotherapy Patient Summits are free educational events that give patients access to experts in the field and advocates who have been treated with immunotherapy. Knowledge is empowering when faced with a cancer diagnosis. Clinical trial navigators are available to assist patients in discovering trials that may benefit them. Cancer Research Institute is a trusted source of information for patients who want to learn more about immunotherapy and it’s potential.
CRI sponsored my lab's research looking into how tumor hypoxia (low oxygen concentration) created a barrier that helped make prostate and pancreatic cancer almost totally immune to the FDA-approved immunotherapy antibodies. This critical support and lead-of-faith from CRI in believing in our work when others did not allowed us to 1) generated critical pre-clinical data to secure a larger grant, 2) published a high-impact paper describing how ablation of hypoxia sensitized prostate cancer to immunotherapy, and 3) eventually launch a clinical trial in which prostate and pancreatic cancer patients are now benefiting from this approach. Thank you CRI for helping us all engage the immune system to wipe out cancer!
The ambition and dedication of CRI in addressing the most urgent questions in the field of cancer immunology and immunotherapy have made a difference to the world. I am very grateful to be supported by CRI to pursue an exciting career in the field and be part of the excellent community.
I am an early-career scientist with a strong interest in understanding how tumors evade the immune system during cancer progression and metastasis. The Cancer Research Institute has been on the forefront of immunotherapy research, and decades of work have paid off with exciting results with new immunotherapy treatments. However, not all tumors respond to immunotherapy, and metastasis remains a leading cause of cancer death. The Cancer Research Institute has directly supported my work on understanding how pancreatic cancer regulates the immune system to allow for tumor growth and the spread of the disease. This work has the potential to provide key insights into strategies for activating an anti-tumor immune response. Thank you, Cancer Research Institute!
I am a postdoctoral researcher fortunate to have been supported by the CRI Irvington Postdoctoral Fellowship. It is truly commendable that CRI recognizes the value of basic immunological research, and that it is committed to supporting young researchers like me who are pursuing these questions.
I am an early career scientist with a research interest in tumor therapy. CRI has provided essential support to help me establish an independent research program and explore new research directions. The application process for CRI funding is straightforward. In recent years, with limited federal funding, financial support from nonprofits, such as CRI is critical for the discovery of new therapies for cancer patients.
I hope those comprising CRI are interested in 2lbs of stevia curing my uncle's 6 in transition phase to cancer breast tumors. He'd just lost his prostate to cancer, and thought his life was over. Adding the facts 62lbs of flab melted off with no hanging/flabby skin, and type 2 diabetes no longer registering makes this seem like a fairy tale, but those results did happen.
Stevia is very high in alkalinity, I've read that a high alkaline diet= a difficult environment for cancer and other diseases from living inside those bodies, and am hoping that someone at CRI is interested in investigating these valid claims.
I am a postdoctoral scientist at Harvard Medical School, studying how the immune system reacts to insults by infections and cancer. CRI is funding my research since the beginning of this year and I am very grateful for this. It is a great honor for me to get awarded a CRI fellowship, which is well-known as a very prestigious fellowship. CRI recognizes the necessity to fund basic research in order to advance the clinic.
As a CRI-funded postdoctoral fellow, I could speak all day about the tireless efforts of the CRI to fund basic and translational research and bring immunotherapy to the clinic. The most significant thing for me is that the CRI awards grants based on scientific merit, regardless of nationality or location of research. Which means that they funded me (a non-American citizen/non-permanent resident) to do cancer research in France. I am greatly indebted to the CRI and its donors for believing in the value of my research, and will continue to work my tail off throughout my career to make their early investment in me a worthwhile one. Thank you CRI!
CRI has played a significant role in my career as a young scientist by funding three years of my postdoctoral research at Caltech. In addition to direct support, I have greatly enjoyed the opportunities CRI has provided to network and collaborate with scientists involved in a very broad range of immunological and cancer research. They do a great job of bringing everyone - from basic researchers to clinicians - to the same table to address really important problems.
The CRI has played an integral part in my development as a scientist and cancer researcher. The organization is perceptive enough to still fund high risk though highly rewarding research. I was lucky enough to receive a postdoctoral research fellowship from them this year to study how intestinal bacteria affect the progression of colorectal cancer using advanced chemical techniques. It is an honor to be included in the outstanding research that is funded and supported by the CRI. A true gem in the cancer research field!
The CRI is supporting my project this year, in which we are trying to develop new strategies for cancer immunotherapy. It's such an honour for me, especially knowing that Lieping, one of the major contributors to the newly breakthrough in immunotherapy, was also supported by the CRI in his early years. The work CRI has supported proves that they have done a really great job in pushing the researches in cancer forward during the past decades.
The CRI began funding my post-doctoral work this year. This has allowed me to work on understanding the immune response to metastasis, however, through the events the CRI runs they have also allowed me to network with other young cancer immunologists producing numerous contacts and potential collaborations which will help move this work forward.
More than 15 years ago I had been very lucky to receive a research fellowship from CRI. That support turned out to be very important in allowing me to finish a study that became my modest contribution to the knowledge of differences in gene regulation between mouse and human immune cells. Later on, I became involved in an educational program in tumor immunology in Moscow, Russia. Due to generous CRI support, we were able to invite very best scientists to come to Moscow specifically for teaching. Many students of that program are now successful young researchers advancing the flourishing field of tumor immunology. Over the years I have attended several CRI symposia and had the privilege of personally meeting a number of CRI administrators and employees including its late scientific director Dr.Lloyd Old. I think Dr.Old was an absolutely great scientist and visionary, and all the members of his team are highly professional bright people dedicated to fighting cancer using immunity. CRI is continuing to do a magnificent job in helping cancer immunology research.
Is a researcher in the field of oncoimmunology, I constantly give CRI top rating for its focused and flexible support and high quality of research and educational programs funded by this remarkable organization. My opinion is based on a number of attempts (both successful and not) to obtain funding from CRI, as well as on impressions from participation in a number of CRI meetings.
The CRI has supported me as a budding researcher in the field of cancer immunotherapy over the past two years. Beyond funding my research in the lab, the CRI has coordinated my interactions with scientists and physicians to inspire new cutting-edge ideas. The CRI also helps to eliminate the disconnect between scientists and patients by setting up meetings with immunotherapy recipients, allowing us to truly see and feel the effect we are having on so many lives. The payoff for their efforts has been fully realized in the last decade, with cancer immunotherapy (their primary focus) being recognized as the Science magazine breakthrough of the year in 2013.
The CRI has been at the forefront of cancer immunology research for decades. The growing success of cancer therapies aimed at the immune system is in no small part due to the efforts of the CRI. As a fellow with CRI funding, I am very grateful for their support, which is allowing me to hone my immunology training for a career in cancer immunology. This organization is not simply a distributor of cash, however. I have been struck by the enthusiasm and optimism of the CRI staff (scientific or otherwise), their desire to engage the public to increase cancer awareness, and their ability to foster a highly collegial environment that is unsurpassed by any other nonprofit I've interacted with. The CRI is doing a great job, and I'm proud to be one of their fellows!
CRI has consistently funded the best people in cancer research to do ground breaking translational research in cancer, and has also provided a cutting edge forum for many years for discussion of the now clearly useful field of cancer immunology.
The research CRI is currently founding has the potential to save many lives and to greatly increase the knowledge of mechanisms underlying the interplay between tumor cells and the immune system. They are definitively doing an amazing job.
I have been supported by CRI postdoctoral fellowship since 2013, just like hundreds of other researchers CRI supported for decades. Thanks to their efforts, promising immune therapies and drugs have been greatly developed in cancer treatment. Although my research is not directly on clinical, the annual symposium provides great opportunity for me to learn about the latest progress on cancer therapies. Sharing researches with clinicians and other CRI fellows inspire novel ideas and facilitate collaborations.